We are live on ! Find out more
ID

Integral Derivatives Portfolio holdings

AUM $4.07B
1-Year Est. Return 19.81%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.85B
AUM Growth
-$635M
Cap. Flow
+$29.4M
Cap. Flow %
0.61%
Top 10 Hldgs %
50.96%
Holding
1,406
New
286
Increased
340
Reduced
405
Closed
335
Avg Time Held Equity + Options
4.2 quarters
Top 10 Avg Time Held Equity + Options
4.9 quarters
Top 20 Avg Time Held Equity + Options
6.2 quarters
Avg Time Held Equity only
1.6 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.9 quarters

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$24.2M
2
META icon
Meta Platforms (Facebook)
META
+$23.3M
3
NFLX icon
Netflix
NFLX
+$9.98M
4
AVGO icon
Broadcom
AVGO
+$6.87M
5
AABA
Altaba Inc
AABA
+$6.36M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$13.5M
2
XOM icon
ExxonMobil
XOM
+$10.4M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$6.62M
4
INTC icon
Intel
INTC
+$6.23M
5
MSFT icon
Microsoft
MSFT
+$5.26M

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.61%
2 Technology 1.76%
3 Communication Services 1.6%
4 Energy 0.75%
5 Consumer Discretionary 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XBI icon
201
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.81B
$3.1M 0.06%
40,100
-34,100
-46% -$2.42M
2016 Q3
3 quarters
LNG icon
202
PUT
Cheniere Energy
LNG
$59B
$3.09M 0.06%
+63,500
New +$3.03M
2017 Q2
0 quarters
CMG icon
203
PUT
Chipotle Mexican Grill
CMG
$38.5B
$3.08M 0.06%
370,000
+185,000
+100% +$1.72M
2014 Q4
10 quarters
MPC icon
204
Marathon Petroleum
MPC
$132B
$3.07M 0.06%
58,721
+43,317
+281% +$2.24M
2017 Q1
1 quarter
CVS icon
205
CVS Health
CVS
$112B
$3.07M 0.06%
38,165
+21,568
+130% +$1.7M
2016 Q4
2 quarters
WDC icon
206
CALL
Western Digital
WDC
$141B
$3.05M 0.06%
45,572
-48,290
-51% -$3.21M
2015 Q3
7 quarters
AZN icon
207
PUT
AstraZeneca
AZN
$244B
$3.05M 0.06%
+44,750
New +$2.92M
2017 Q2
0 quarters
USO icon
208
CALL
United States Oil Fund
USO
$1.95B
$3.05M 0.06%
40,088
-10,387
-21% -$831K
2014 Q4
10 quarters
FDX icon
209
FedEx
FDX
$68.5B
$3.05M 0.06%
+14,016
New +$2.77M
2017 Q2
0 quarters
DVN icon
210
Devon Energy
DVN
$54.7B
$3.04M 0.06%
+94,993
New +$3.47M
2017 Q2
0 quarters
JD icon
211
CALL
JD.com
JD
$36.2B
$3.04M 0.06%
77,400
+17,200
+29% +$649K
2014 Q3
11 quarters
SPLK icon
212
CALL
DELISTED
Splunk Inc
SPLK
$3.03M 0.06%
53,300
+100
+0.2% +$6.22K
2015 Q2
8 quarters
AMAT icon
213
CALL
Applied Materials
AMAT
$369B
$3.03M 0.06%
73,300
-8,100
-10% -$344K
2014 Q3
11 quarters
DVN icon
214
CALL
Devon Energy
DVN
$54.7B
$3.01M 0.06%
94,200
-59,400
-39% -$2.17M
2013 Q4
14 quarters
SBUX icon
215
CALL
Starbucks
SBUX
$104B
$2.99M 0.06%
51,300
+10,600
+26% +$641K
2014 Q3
11 quarters
MET icon
216
CALL
MetLife
MET
$63.7B
$2.97M 0.06%
60,588
+224
+0.4% +$10.4K
2015 Q2
8 quarters
CL icon
217
CALL
Colgate-Palmolive
CL
$71.5B
$2.96M 0.06%
40,000
+30,600
+326% +$2.27M
2017 Q1
1 quarter
XOP icon
218
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.27B
$2.95M 0.06%
23,101
-8,005
-26% -$1.09M
2016 Q3
3 quarters
XLV icon
219
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$2.95M 0.06%
37,200
+23,800
+178% +$1.81M
2016 Q3
3 quarters
BMY icon
220
CALL
Bristol-Myers Squibb
BMY
$116B
$2.92M 0.06%
52,500
-6,400
-11% -$348K
2013 Q4
14 quarters
HYG icon
221
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$2.92M 0.06%
33,000
-83,100
-72% -$7.31M
2015 Q4
6 quarters
V icon
222
CALL
Visa
V
$738B
$2.92M 0.06%
31,100
+17,400
+127% +$1.61M
2014 Q4
10 quarters
BG icon
223
CALL
Bunge Global
BG
$20.7B
$2.88M 0.06%
+38,600
New +$2.94M
2017 Q2
0 quarters
MET icon
224
PUT
MetLife
MET
$63.7B
$2.87M 0.06%
58,681
+29,733
+103% +$1.38M
2014 Q3
11 quarters
UNH icon
225
PUT
UnitedHealth
UNH
$343B
$2.85M 0.06%
15,400
-300
-2% -$52.6K
2014 Q2
12 quarters

Similar funds

Integral Derivatives's Q2 2017 Portfolio in Review

As of Q2 2017, Integral Derivatives held 1,406 positions worth $4.85B, down 12% from $5.49B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Integral Derivatives's Q2 2017 filing shows 286 new, 340 increased, 405 reduced and 335 closed positions. Its largest new stake was Broadcom: 296,230 shares worth $6.9M. The largest sale was IBM, an estimated $13.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Technology and Communication Services.

  • Integral Derivatives's largest Q2 2017 buy was Broadcom: 296,230 shares worth $6.9M.
  • Integral Derivatives added most to Apple in Q2 2017, an estimated $24.2M increase.
  • Integral Derivatives's biggest Q2 2017 reduction was IBM, cutting an estimated $13.5M.
  • Integral Derivatives fully exited Intel in Q2 2017, selling an estimated $6.23M.
  • Integral Derivatives's ten largest holdings make up 51% of its $4.85B portfolio in Q2 2017.
  • Integral Derivatives opened 286 new positions and closed 335 in Q2 2017.
  • Integral Derivatives's portfolio value fell 12% quarter-over-quarter to $4.85B.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.